AspirinWarfarinAnticoagulantsPlatelet Aggregation InhibitorsVitamin K Epoxide ReductasesAnti-Inflammatory Agents, Non-SteroidalHemorrhageThromboembolismTiclopidineAtrial FibrillationProthrombin TimeThromboxane B2Platelet AggregationCyclooxygenase InhibitorsSalicylatesMixed Function OxygenasesDrug Therapy, Combinationbeta-AlanineVitamin KStrokePlatelet Function TestsFibrinolytic AgentsAryl Hydrocarbon HydroxylasesDrug InteractionsThrombosisDose-Response Relationship, DrugPharmacogeneticsRodenticidesBlood PlateletsSodium SalicylateGastrointestinal HemorrhageTreatment OutcomeRisk FactorsDouble-Blind MethodAsthma, Aspirin-InducedBlood CoagulationTablets, Enteric-CoatedPlatelet ActivationDrug ResistanceProspective StudiesAdministration, OralPhenylbutazoneCyclooxygenase 1Drug MonitoringIbuprofenTime FactorsBleeding TimeProstaglandin-Endoperoxide SynthasesVitamin K 1ThromboxanesIntracranial HemorrhagesEmbolismDipyridamoleThromboxane A2HeparinHeparin, Low-Molecular-WeightFollow-Up StudiesCyclooxygenase 2 InhibitorsMyocardial InfarctionBenzimidazolesDrug Administration ScheduleDrug Dosage CalculationsAcetaminophenSulfinpyrazone4-HydroxycoumarinsLipoxinsCohort StudiesRecurrenceRisk AssessmentVenous ThrombosisIndomethacinRandomized Controlled Trials as TopicCerebrovascular DisordersRetrospective StudiesGastric MucosaCyclooxygenase 2Primary PreventionThrombophlebitisReye SyndromePyridonesStomach UlcerProstaglandinsAntithrombinsNaproxenIncidence